Healthcare

Image

Global Herpes Market – Industry Trends and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Herpes Market, By Virus Type (Herpes Simplex and Herpes Zoster), Product (Acyclovir, Docosanol, Valacyclovir, Famciclovir and Others), Drug Type (Prescription Drug and Over-the-counter Drug), Age (Adult and Pediatrics), Route Of Administration (Topical, Oral, and Parenteral), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others), End Users (Speciality Clinics, and Others) – Industry Trends and Forecast to 2031.

Herpes Market

Herpes Market Analysis and Size

The herpes market encompasses prescription and over-the-counter drugs targeting herpes simplex virus (HSV) infections. Prescription medications such as valacyclovir (Valtrex) are widely used for managing outbreaks and suppressing viral activity. Over-the-counter options, such as topical creams containing docosanol (Abreva), offer symptomatic relief. This market addresses both acute treatments and long-term management of HSV infections, catering to varying consumer needs and preferences.

Data Bridge Market Research analyses that the global herpes market, which was USD 1.24 billion in 2023, is expected to reach USD 2.06 billion by 2031, at a CAGR of 6.6% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Herpes Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Virus Type (Herpes Simplex and Herpes Zoster), Product (Acyclovir, Docosanol, Valacyclovir, Famciclovir and Others), Drug Type (Prescription Drug and Over-the-counter Drug), Age (Adult and Pediatrics), Route Of Administration (Topical, Oral, and Parenteral), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others), End Users (Hospitals, Speciality Clinics, and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Abbott (U.S.), Apotex, Inc. (Canada), Avet Pharmaceuticals, Inc. (U.S.), Bausch Health Companies, Inc. (Canada), Cipla, Inc. (India), Dr. Reddy’s Laboratories Ltd. (India), Fresenius Kabi AG (Germany), GSK plc (U.K.), GLENMARK PHARMACEUTICALS LTD (India), Maruho Co.,Ltd. (Japan), Mylan N.V. (U.S.), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Zydus Pharmaceuticals, Inc. (India), Recordati Industria Chimica e Farmaceutica S.p.A. (Italy), Aurobindo Pharma (India), Amneal Pharmaceuticals LLC (U.S.), Slavia Pharm S.R.L. (Romania), Blistex, Inc. (U.S.)

Market Opportunities

  • Personalized Medicine Approaches for Improved Efficacy
  • Telemedicine Platforms Expanding Access to Care

Market Definition

Herpes is a viral infection caused by herpes simplex virus (HSV), characterized by recurrent outbreaks of painful blisters or sores. HSV-1 primarily affects the mouth and face, while HSV-2 typically targets the genital area. It spreads through direct contact with infected individuals, and symptoms may include itching, tingling, and burning sensations.

Global Herpes Market Dynamics

Drivers

  • Increasing Awareness about Prevention and Treatment

Efforts in public health campaigns, educational initiatives, and advocacy programs have heightened understanding about herpes transmission, symptoms, and available treatments. As awareness grows, individuals are more inclined to seek preventive measures and treatment options, contributing to market expansion. Ultimately, this heightened awareness serves as a significant driver propelling the herpes market forward.

  • Improved Diagnostic Technologies Enhancing Early Detection

Advanced testing methods such as PCR assays and serological tests enable quicker and more accurate identification of herpes infections. Early detection facilitates prompt initiation of treatment, reducing transmission rates and severity of symptoms. Consequently, the demand for these diagnostic tools surges, serving as a pivotal driver propelling growth within the herpes market.

Opportunities

  • Personalized Medicine Approaches for Improved Efficacy

Personalized medicine in the herpes market tailors treatment to individual patients based on genetic, environmental, and lifestyle factors. This approach allows for precise identification of the most effective therapies for each patient, potentially reducing side effects and improving outcomes. With advancements in genetic testing and data analytics, personalized medicine presents an opportunity to optimize treatment strategies and better manage herpes infections, meeting the diverse needs of patients while enhancing overall efficacy.

  • Telemedicine Platforms Expanding Access to Care

Telemedicine platforms offer convenient access to herpes care, enabling remote consultations, prescriptions, and follow-ups. This approach eliminates geographical barriers, especially in underserved areas, and enhances patient engagement. With the rise of virtual healthcare, individuals can seek timely treatment and advice without the need for in-person visits. In the herpes market, leveraging telemedicine platforms presents an opportunity to improve accessibility, increase patient satisfaction, and ultimately optimize disease management.

Restraints/Challenges

  • Regulatory Hurdles Delay Approval of New Treatments

The regulatory hurdles delays prolong the introduction of innovative therapies, limiting the market's ability to offer advanced solutions. Consequently, patients may face continued reliance on existing treatments, potentially hindering their efficacy and overall satisfaction. Moreover, the slower pace of introducing new products could stifle competition and innovation within the market, impacting its overall growth potential and the ability to address evolving patient needs.    

  • High Cost of Prescription Medications Hinders Access

The high cost of prescription medications limits the affordability of necessary treatments, potentially leading to financial strain or the inability to obtain medication altogether. As a result, individuals may forego or delay treatment, leading to prolonged suffering and increased transmission risks. Moreover, the financial burden on patients could discourage them from seeking proper medical care, impacting the market's overall revenue and growth potential.

This global herpes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global herpes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In October 2022, Replay, a genome writing company, introduced Eudora, a gene therapy firm focused on treating genetic retinal diseases using synHSV, a high payload capacity HSV delivery vector. This marks the debut of Replay's product companies utilizing synHSV, signaling a significant advancement in HSV-based gene therapy within the herpes market
  • In August 2022, Rational Vaccines began a clinical trial in the U.K. to evaluate baseline characteristics of patients with recurrent symptomatic HSV type 2, informing protocol design for their lead HSV-2 therapeutic vaccine candidate. This underscores Rational Vaccines' commitment to advancing herpes treatment and prevention, aiming to revolutionize disease management within the herpes market

Global Herpes Market Scope

The global herpes market is segmented on the basis of virus type, product, drug type, age, route of administration, distribution channel, and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Virus Type

  • Herpes Simplex
  • Herpes Zoster

Product

  • Acyclovir
  • Docosanol
  • Valacyclovir
  • Famciclovir
  • Others

Drug Type

  • Prescription Drug
  • Over-the-counter Drug

 Age

  • Adult
  • Pediatrics

Route of Administration

  • Topical
  • Oral
  • Parenteral

 Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others

 End Users

  • Hospitals
  • Speciality Clinics
  • Others

Global Herpes Market Regional Analysis/Insights

The global herpes market is analysed and market size insights and trends are provided by virus type, product, drug type, age, route of administration, distribution channel, and end users as referenced above.

The countries covered in the global herpes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to lead the global herpes market, driven by a rising prevalence of herpes infections in the region. The U.S., in particular, dominates this market, spearheading growth due to escalating herpes cases. This underscores the region's pivotal role in shaping the trajectory of the herpes market on a global scale.

The Asia-Pacific region anticipates significant growth in the herpes market from 2024 to 2031, attributed to an increasing geriatric population in countries such as China, Japan, and India. China leads this growth, fueled by rising disposable income levels. This underscores a growing market opportunity driven by demographic shifts and economic factors in the region.

Europe expects substantial growth in the herpes market from 2024 to 2031, driven by technological advancements in the region. Germany dominates within Europe, benefitting from a robust presence of market players. This highlights the pivotal role of technology and competitive landscape in shaping the herpes market's trajectory in Europe.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The global herpes market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global herpes market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global herpes market. The data is available for historic period 2016-2021.

Competitive Landscape and Global Herpes Market Share Analysis

The global herpes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global herpes market.

Some of the major players operating in the global herpes market are:

  • Abbott (U.S.)
  • Apotex, Inc. (Canada)
  • Avet Pharmaceuticals, Inc. (U.S.)
  • Bausch Health Companies, Inc. (Canada)
  • Cipla, Inc. (India)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Fresenius Kabi AG (Germany)
  • GSK plc (U.K.)
  • GLENMARK PHARMACEUTICALS LTD (India)
  • Maruho Co.,Ltd. (Japan)
  • Mylan N.V. (U.S.)
  • Pfizer Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Zydus Pharmaceuticals, Inc. (India)
  • Recordati Industria Chimica e Farmaceutica S.p.A. (Italy)
  • Aurobindo Pharma (India)
  • Amneal Pharmaceuticals LLC (U.S.)
  • Slavia Pharm S.R.L. (Romania)
  • Blistex, Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The herpes market size will be worth USD 2.06 billion by 2031.
The growth rate of the herpes market is 6.6% in the forecast period by 2031.
Increasing awareness about prevention and treatment & improved diagnostic technologies enhancing early detection are the growth drivers of the herpes market.
Virus type, product, drug type, age, route of administration, distribution channel, and end users are the factors on which the herpes market research is based.
Major companies in the herpes market are Abbott (U.S.), Apotex, Inc. (Canada), Avet Pharmaceuticals, Inc. (U.S.), Bausch Health Companies, Inc. (Canada), Cipla, Inc. (India), Dr. Reddy’s Laboratories Ltd. (India), Fresenius Kabi AG (Germany), GSK plc (U.K.), GLENMARK PHARMACEUTICALS LTD (India), Maruho Co.,Ltd. (Japan), Mylan N.V. (U.S.), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Zydus Pharmaceuticals, Inc. (India), Recordati Industria Chimica e Farmaceutica S.p.A. (Italy), Aurobindo Pharma (India), Amneal Pharmaceuticals LLC (U.S.), Slavia Pharm S.R.L. (Romania), Blistex, Inc. (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials